Upexi, Inc.
NASDAQ:UPXIInternet Content & Information
-$0.04 today
- Market cap
- $51.54M
- Beta
- -0.33
- P/E (TTM)
- -0.3
- EPS (TTM)
- -$3.49
Volume 0.93M
Average 3.19M
UPXI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Upexi, Inc.NASDAQ: UPXI
Research & Development · Q3 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 0 | — |
| FY2024 | 2024-06-30 | 0 | — |
| FY2023 | 2023-06-30 | 0 | — |
| FY2022 | 2022-06-30 | 0 | — |
| FY2021 | 2021-06-30 | 0 | — |
Research & Development vs competitors
How UPXI compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for UPXI, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | €25.39M EUR | +97.2% | — | 4.5% | |
| LTM Mar 2026 | $20.72M USD | +12.0% | -1.4% | 28.2% | |
| LTM Mar 2026 | $5.76M USD | -1.1% | +13.1% | 7.9% | |
| LTM Mar 2026 | $1.11M USD | — | — | 0.9% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding UPXI) | — | +12.0% | +5.9% | 0.0% | |
Competitors are the stored peer set for UPXI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 24.1M | 23.07M | 36.44M | 26M | 15.81M |
| Cost of Revenue | 12.2M | 8.2M | 15.42M | 13.18M | 4.94M |
| Gross Profit | 11.9M | 14.87M | 21.02M | 12.82M | 10.87M |
| Gross Margin | 49.4% | 64.5% | 57.7% | 49.3% | 68.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 9.44M | 19.8M | 26.07M | 22.54M | 22.99M |
| Operating Expenses | 10.47M | 21.36M | 33.3M | 35.29M | 23.37M |
| Depreciation & Amortization | 1.03M | 2.73M | 3.48M | 3.68M | 757.76K |
| EBITDA | 3.26M | (3.45M) | (5.05M) | (9.72M) | (12.12M) |
| EBITDA Margin | 13.5% | -15.0% | -13.9% | -37.4% | -76.6% |
| Operating Income | 1.43M | (6.49M) | (12.28M) | (22.46M) | (12.5M) |
| Operating Margin | 5.9% | -28.1% | -33.7% | -86.4% | -79.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 530.45K | 202.12K | 4.72M | 3.12M | 1.17M |
| Other Income / Expenses | 269.4K | 101.08K | (4.68M) | (3.14M) | (1.18M) |
| Income Before Tax | 1.7M | (6.39M) | (16.96M) | (25.6M) | (13.68M) |
| Pre-Tax Margin | 7.0% | -27.7% | -46.5% | -98.5% | -86.5% |
| Income Tax Expense | (1.28M) | (518.4K) | (3.05M) | (332.1K) | 0 |
| Net Income | 2.98M | (2.1M) | (16.93M) | (23.66M) | (13.68M) |
| Net Margin | 12.4% | -9.1% | -46.5% | -91.0% | -86.5% |
| EPS (Basic) | 5.00 | (0.13) | (16.46) | (24.16) | (1.73) |
| EPS (Diluted) | 4.20 | (0.13) | (16.46) | (24.16) | (1.73) |
| Weighted Avg Shares | 596.52K | 16.22M | 17.88M | 1.03M | 7.91M |
| Weighted Avg Shares (Diluted) | 712.9K | 16.22M | 17.88M | 1.03M | 7.91M |
Upexi, Inc.
NASDAQ:UPXI
Intrinsic Alpha fair value
Locked
Current Price
$0.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.